16 December 2019


Exciting health innovations from across Europe are being introduced to organisations in the North West Coast thanks to an international programme involving the Innovation Agency.

The Bridgehead programme identifies well-evidenced products and matches them with organisations such as the Innovation Agency who then introduce them to local health and care providers.

It means that the North West Coast is able to adopt best-in-class solutions and carry out real-world evaluations which benefit patients, at no cost to the NHS.

The programme is funded by EIT Health and aims to help small companies with promising offers to expand beyond their home markets.  There are 15 products currently being offered for local trials through the Innovation Agency, including:

  • Mode Vivo, the first clinical-grade sensor patch system for early detection and prevention of dehydration;
  • QT Robot, a social humanoid robot that combines the latest advancements in the robotics technology and evidence-based educational content to make autism training effective, available and affordable; and
  • LactApp, a comprehensive mobile breastfeeding and postnatal support tool powered by artificial intelligence which provides expert, confidential and personalised breastfeeding advice with 76,000 possible advice paths providing more than 2,300 answers. The app autonomously resolves more than 35,000 weekly queries worldwide on a personalised basis.

Innovation Agency Associate Director for Partnerships Lindsay Sharples said: “This is a fantastic opportunity for innovative NHS and social care organisations to access amazing products with the potential to improve care for patients.

“We act as the facilitator and supporter and if anyone would like to find out more, with no obligation, please get in touch.”

The Innovation Agency supports the companies through business case development, advice on procurement and engagement with decision-makers and influencers. They help to manage the relationship between the company and the adopting organisation and ensure the right evaluation and regulatory requirements are met.

Other products being introduced are:

CoNurse Guideline Adherence and Management System: A voice-guided application for improving quality and reducing avoidable medical errors and patient harm in hospital settings.

Eodyne: Neuro-rehabilitation Gaming System: A science-based treatment for effective recovery after brain damage.

Sensius HyperCollar3D: A hyperthermia treatment for head-and-neck cancer patients developed at the Erasmus MC Cancer Institute.

eHTA WIVI Vision: A digital platform for the assessment and treatment of children with visual dysfunctions, personalised for each user and based on immersive Clinical 3D and AI algorithms.

Qubiotech Neurocloud Platform: An online platform designed to host an ecosystem of fully automatic and clinically validated quantification and diagnostic tools that provide quantitative and visual information of PET, SPECT and MRI images in a few minutes, allowing integration within the clinical workflow.

Sleepiz: A medical device and software solution for the non-contact measurement and analysis of human vital signs to diagnose sleep apnoea at a patient’s home without having to attach any physical sensors or wires to the patient’s body.

Vitadio: A programme that helps diabetes type 2 patients permanently reduce weight, maintain proper blood sugar levels and return to an active life using data-driven high-touch lifestyle interventions.

MOWOOT: The first intermittent colonic exo-peristalsis device on the market: a class IIa medical device (CE) providing a non-pharmacological, non-invasive solution for patients with chronic constipation.

Lifeguard: A digital platform for organisations who want to address the health challenges of their workforce due to obesity, stress and inactive life styles and help their employees become healthier.

Psious: A VR platform for mental health therapy. VR allows therapists to expose patients to situations in a controlled way and therapy can be delivered in person and remotely to offer the patient choice.

HandInScan: A medical device focusing on the prevention of healthcare-associated infections. The Semmelweis Scanner examines what areas are covered on the hands after regular hand disinfection with a hand rub. It also provides immediate quality-assured feedback regarding hand hygiene.

Any health or social care professional interested in trying out one of these products is asked to email:

How digital solutions saved our skin during Covid19 Read more

As a consultant dermatologist I was already interested in innovation but the sudden onset of COVID-19 made it happen sooner rather than later. Covidblogs

Visors, ventilators – and innovation Read more

After receiving SBRI funding we have been working for the last 18 months on a laparoscopic simulator, the  LapAR™, which combines a box trainer set with the high fidelity of a virtual reality system, it is completely unique. Covidblogs

Neonatal telemedicine: Dr Chris Dewhurst Read more

Liverpool is unique for neonatal services because babies are born in one hospital, Liverpool Women’s, but if they need specialist services those are provided in a different hospital, Alder Hey. We have been working to develop a neonatal unit..

Data project drives improvements in care for patients Read more

Millions of people across the North West Coast will benefit from improved health thanks to a project aimed at better managing patient data. Connected Health Cities, which involved the Innovation Agency, was a £20m, four-year pilot funded by the Department..

All the latest from the Innovation Agency...

Health Coaching